Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 9, 2011, Pages 1918-1924

  Sakai, Eiji ^a   Takahashi, Hirokazu ^a   Kato, Shingo ^a   Uchiyama, Takashi ^a   Hosono, Kunihiro ^a   Endo, Hiroki ^a   Maeda, Shin ^a   Yoneda, Masato ^a   Taguri, Masataka ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABERRANT CRYPT FOCUS; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CARCINOGENESIS; CHROMOENDOSCOPY; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; GENDER; HEALTH BEHAVIOR; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMOKING;

ABERRANT CRYPT FOCI; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 80052518171     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0104     Document Type: Article

References (37)

1. Rougier P., Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 2003;14 Suppl 2:ii3-ii5 (Pubitemid 36874131)
2. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329: 1977-1981 (Pubitemid 24015040)
3. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1966;87:159-170
4. Winawer S.J. Screening of colorectal cancer. Surg Oncol Clin N Am 2005;14:699-722. (Pubitemid 41446313)
5. Matsuhashi N., Nakajima A., Fukushima Y., Yazaki Y., Oka T. Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 1997;40: 344-349 (Pubitemid 27145647)
6. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987;37:147-151 (Pubitemid 17157833)
7. McLellan E.A., Bird R.P. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res 1998;48:6183-6186
8. McLellan E.A., Bird R.P. Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Res 1988;48:6187-6192 (Pubitemid 18266821)
9. McLellan E.A., Medline A., Bird R.P. Dose response and proliferative characteristics of aberrant crypt foci: Putative preneoplastic lesions in rat colon. Carcinogenesis 1991;12:2093-2098
10. McLellan E.A., Medline A., Bird R.P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: Putative preneoplastic lesions. Cancer Res 1991;51:5270-5274
11. McLellan E., Bird R.P. Effect of disulfiram on 1,2-dimethylhydrazine-and azoxymethane-induced aberrant crypt foci. Carcinogenesis 1991;12:969-972
12. Pretlow T.P., Barrow B.J., Ashton W.S., O'Riordan M.A., Pretlow T.G., Jurcisek J.A., et al. Aberrant crypts: Putative preneoplastic foci in human colonic mucosa. Cancer Res 1991;51:1564-1567
13. Roncucci L., Medline A., Bruce W.R. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1991;1:57-60.
14. Shpitz B., Bomstein Y., Mekori Y., Cohen R., Kaufman Z., Neufeld D., et al. Aberrant crypt foci in human colon: Distribution and histomorphologic characteristics. Human Pathol 1998;29:469-475 (Pubitemid 28213466)
15. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339:1277-1284 (Pubitemid 28496193)
16. Adler D.G., Gostout C.J., Sorbi D., Burgart L.J., Wang L., Harmsen W.A. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc 2002;56:657-662 (Pubitemid 36531699)
17. Hurlstone D.P., Karajeh M., Sanders D.S., Drew S.K., Cross S.S. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: Biomarkers for flat and depressed neoplasia. Am J Gastroentrol 2005;100:1283-1289 (Pubitemid 40904350)
18. Seike K., Koda K., Oda K., Kosugi C., Shimizu K., Nishimura M., et al. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms. Am J Gastroenterol 2006;101:1362-1369 (Pubitemid 43830006)
19. Kim J., Ng J., Arozulllah A., Ewing R., Llor X., Carroll R.E., et al. Aberrant crypt focus size predicts distal polyp histopathology. Cancer Epidemiol Biomarkers Prev 2008;17:1152-1162
20. Rudolph R.E., Dominitz J.A., Lampe J.W., Lewy L., Qu P., Li S.S., et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev 2005;14: 605-608 (Pubitemid 40489202)
21. Moxon D., Raza M., Kenny R., Ewing R., Arozullah A., Mason J.B., et al. Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population. Clin Gastroenterol Hepatol 2005;3:271-278 (Pubitemid 40568733)
22. Stevens R.G., Swede H., Heinen C.D., Jablonski M., Grupka M., Ross B., et al. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer. Cancer Lett 2007;248:262-268 (Pubitemid 46343762)
23. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725-731 (Pubitemid 32695151)
24. Liang P.S., Chen T.Y., Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009;124:2406-2415
25. Pedersen A., Johansen C., Gronbaek M. Relation between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut 2003;52:861-867 (Pubitemid 36613494)
26. Shimizu N., Nagata C., Shimizu H., Kametani M., Takeyama N., Ohmura T., et al. Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: A prospective study. Br J Cancer 2003;88:1038-1043 (Pubitemid 36560772)
27. Cho E., Smith-Warner S.A., Ritz J., Van den Brandt P.A., Colditz G.A., Folsom A.R., et al. Alcohol intake and colorectal cancer: A pooled analysis of 8 cohort studies. Ann Intern Med 2004;140:603-613
28. Moghaddam A.A., Woodward M., Huxley R. Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007;16:2533-2547 (Pubitemid 351196307)
29. Tsong W.H., Koh W.P., Yuan J.M., Wang R., Sun C.L., YuMC. Cigarette and alcohol in relation to colorectal cancer: The Singapore Chinese health study. Br J Cancer 2007;96:821-828
30. Acott A.A., Theus S.A., Marchant-Miros K.E., Mancino A.T. Association of tobacco and alcohol use with earlier development of colorectal cancer: Should we modify screening guidelines? Am J Pathol 2008; 196:915-918
31. Povey A., Hall C.N., Badawi A.F., Cooper D.P., O'Connor P.J. Elevated levels of the pro-carcinogenic adduct, 06 methylguanine, in normal DNA from the cancer prone regions of the large bowel. Gut 2000; 47:362-365
32. Jung A.Y., Poole E.M., Bigler J., Whitton J., Potter J.D., Ulrich C.M. DNA methyltransferase and alcohol dehydrogenase: Gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008;17:330-338 (Pubitemid 351272783)
33. Mutch M.G., Schoen R.E., Fleshman J.W., Rall C.J., Dry S., Seligsone D., et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol 2009;7:568-574
34. Cho N.L., Redston M., Zauber A.G., Carothers A.M., Hornick J., Wilton A., et al. Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res 2008;1:21-31.
35. Hosono K., Endo H., Takahashi H., Sugiyama M., Sakai E., Uchiyama T., et al. Metformin suppresses colorectal aberrant crypt foci in a shortterm clinical trial. Cancer Prev Res 2010;3:1077-1083
36. Takayama T., Nagashima H., Maeda M., Nojiri S., Hirayama M., Nakano Y., et al. Randomized double blind trial of sulindac and etodolac to eradicate aberrant crypt foci and prevent sporadic colorectal polyps. Clin Cancer Res 2011;17:3803-3811
37. Polyak K., Hamilton S.R., Volgelstein B., Kinzler K.W. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 1996;149:381-387 (Pubitemid 26256327)